https://www.selleckchem.com/pr....oducts/lificiguat-yc
To compare the use of benzodiazepines, z-hypnotics, gabapentinoids, opioids and centrally acting stimulants (CAS) among patients who had received opioid agonist therapy (OAT) in Norway and Sweden during the period 2015 - 2017. A register-based prospective cohort study using information about dispensed drugs from the Norwegian Prescription Database and Swedish Prescribed Drug Register. Patients who were dispensed OAT opioids from pharmacies. A total of 7176 Norwegian and 3591 Swedish patients on OAT were included. The number and
Like
Comment
Share
